Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

Clinical trial NCT04274049 · COMPLETED

Trial details

NCT number: NCT04274049
Sponsor: Beijing Northland Biotech. Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arterial Occlusive Disease Ischemia Ulcers Peripheral Vascular Disease

Start date: 2019-08-28
Primary completion: 2023-12-23
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.